Measuring cytotoxicity: A new perspective on LC50

Anticancer Research

Volumn 27, Issue 1 A, 2007, Pages 35-38

  Zhang, Ming ^a   Aguilera, Dolly ^a   Das, Chandra ^a   Vasquez, Hernan ^a   Zage, Peter ^a   Gopalakrishnan, Vidya ^a   Wolff, Johannes ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cytotoxicity; LC50; Lethal concentration

Indexed keywords

N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE;

ARTICLE; CELL GROWTH; CYTOTOXICITY TEST; GLIOMA CELL; HUMAN; HUMAN CELL; INCUBATION TIME; LC 50; MEASUREMENT; MEDULLOBLASTOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BENZAMIDES; CELL LINE, TUMOR; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MALE; MEDULLOBLASTOMA; MODELS, BIOLOGICAL; PYRIDINES;

EID: 33847635250     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. 50, and fixed-dose acute toxicity procedures. Food Chem Toxicol 33: 223-231, 1995.
2. Trevan JW: The error of determination of toxicity. Proceedings of the Royal Society 101B: 483-514, 1927.
3. 50 values for several stages of the marine copepod Tigriopus brevicornis (Muller) exposed to the metals arsenic and cadmium and the pesticides atrazine, carbofuran, dichlorvos, and malathion. Ecotoxicol Environ Saf 40: 239-244, 1998.
4. 50 testing. Regul Toxicol Pharmacol 15: 278-290, 1992.
5. Wolff JEA, Trilling T, Molenkamp G, Egeler RM and Juergens H: Chemosensitivity of glioma cells in vitro: a meta analysis. J Cancer Res Clin Oncol 125: 481-486, 1999.
6. Wolff JEA, Galla HG and Poppenborg H: Long recovery times improve the detection of cellular resistance in vitro. J Cancer Res Clin Oncol 124: 409-414, 1998.
7. Laird AK: Dynamics of tumor growth: Comparison of growth rates and extrapolation of growth curves to one cell. Br J Cancer 20: 278-291, 1965.
8. Levasseur LM, Slocum HK, Rustum YM and Greco WR: Modeling of the time-dependency of in vitro drug cytotoxicity and resistance. Cancer Res 58: 5749-5761, 1998.
9. Swanson KR, Bridge C, Murray JD and Alvord EC: Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J Neurol Sci 216: 1-10, 2003.
10. Zhang M, Das C, Vasquez H, Aguilera D, Zage P, Gopalakrishnan V and Wolff J: Predicting tumor cell repopulation after response: mathematical modeling of cancer cell growth. Anticancer Res 26(4B): 2933-2936, 2006.
11. Draper N and Smith H: Applied Regression Analysis. New York, Wiley-Interscience, 3rd Edition, pp. 505, 1998.
12. Jaboin J, Wild J, Hamidi H, Khanna C, Kim CJ, Robey R, Bates SE and Thiele CJ: MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors. Cancer Res 62: 6108-6115, 2002.
13. Li XN, Shu Q, Su JM, Perlaky L, Blaney SM and Lau CC: Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol Cancer Ther 4: 1912-1922, 2005.
14. Sonnemann J, Kumar KS, Heesch S, Muller C, Hartwig C, Maass M, Bader P and Beck JF: Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. Int J Oncol 28: 755-766, 2006.